跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CARLEVENT levodopa/carbidopa/entacapone 125/31.25/200 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
CARLEVENT levodopa/carbidopa/entacapone 125/31.25/200 mg tablet bottle
Approved
STANDARD
CARLEVENT levodopa/carbidopa/entacapone 125/31.25/200 mg tablet bottle
Medis Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
6dd93678d557a817
Company
Medis Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
6dd93678d557a817
Product Name
CARLEVENT levodopa/carbidopa/entacapone 125/31.25/200 mg tablet bottle
Artg Id
195748
Artg Name
CARLEVENT levodopa/carbidopa/entacapone 125/31.25/200 mg tablet bottle
Sponsor
Medis Pharma Pty Ltd
Company Detail Path
/organization/medis-pharma-pty-ltd
Artg Date
2013-10-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-02202-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-PI-02762-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
6dd93678d557a817
Type
Standard
Back to TGA Approvals